Morning Breakouts

Latest KFF Health News Stories

Hospitals Employ New Strategies In Attempt To Control Rising Drug Costs

Morning Briefing

In related news, 11 Democratic senators – including presidential candidate Bernie Sanders — are urging the Food and Drug Administration and the Department of Health and Human Services to examine the impact of the drug company practice of selling “one-size-fits-all” vials of drugs to treat cancer and other deadly diseases.

Bristol-Myers Outflanks Merck By Embracing Old, Mass-Marketing Approach On Cancer Drug

Morning Briefing

The two companies are offering a comparable drug, but doctors are flocking to Bristol’s to bypass the testing process required for Merck’s. In other pharmaceutical news, Valeant is trying to calm wary investors as its Tuesday earning report draws near, the stock market reflects the uncertainty surrounding the Pfizer-Allergan deal and Martin Shkreli’s old drug company gets an offer.

By End Of 2015, Obamacare Enrollment Off Target By 3 Percent

Morning Briefing

Over the course of the year, the number of people signed up and paying premiums on exchange plans went down 25 percent, from 11.7 million to 8.8 million. In other health law news, a few of the troubled insurance cooperatives could turn profits in 2016. And Blue Cross and Blue Shield of Illinois hopes for a financial turnaround after last year’s flop.

S.D. Governor Signs Legislation Banning Abortion After 19 Weeks Of Pregnancy

Morning Briefing

The legislation includes exceptions for medical emergencies, but not for cases of rape or incest. Elsewhere, The Associated Press takes a closer look at Indiana’s measure that would ban abortions sought because of fetal defects, and West Virginia lawmakers override the governor’s veto on banning a second-trimester abortion method.

VA Investigation Finds Systemic Scheduling Problems At Texas Facilities

Morning Briefing

According to the report, schedulers often listed the first available date that a patient could be seen as the date that a patient had wanted to be seen. Meanwhile, a new report says more Agent Orange research is long overdue.

Long Road Ahead For Genetically Modified Mosquito Trial In Florida

Morning Briefing

To help in the battle against Zika, the Florida Keys Mosquito Control District wants Oxitec, a company that has developed genetically modified mosquitoes that would help cull the population, to test them in a neighborhood of 444 homes on a peninsula north of Key West, but it’s not going to happen anytime soon. In other Zika news, NPR looks at problems with testing, such as long wait times for results, and health experts in Ohio lead the crusade against the virus.

Where Do Older Americans Get Best Health Care? Group Issues Report Cards

Morning Briefing

The Dartmouth Institute for Health Policy and Clinical Practice based its regional ratings on factors like time spent with a doctor, likelihood of hospitalization and number of unnecessary tests or risky medications. Meanwhile, KHN reports on the latest preventive care guidance on eye exams for seniors.

A Kayak.com For Drug Trial Sign-Ups?

Morning Briefing

An entrepreneur is taking a page from the travel industry with a new tool he thinks could tackle a long-standing inefficiency that’s hobbled the pharmaceutical industry for years — matching scientists to patients with the disease.

Making It Easier To See The Doctor — Minute Clinics And ER Adjustments

Morning Briefing

NPR reports on how some hospital emergency rooms are adapting to make it easier to provide regular care to patients. Meanwhile, The Washington Post notes that minute clinics are making more people more likely to go to the doctor.

A Tragedy Becomes A Crucible Moment For Texas Hospital

Morning Briefing

The death of a 13-year-old boy who suffered a stroke and sought treatment from Hill Country Memorial was a turning point for the hospital, which had been struggling with budget and poor customer and employee satisfaction. But other rural hospitals have not fared as well.